MRVL

Marvell Technology

$122.28

-11.69%
Nov 20, 2026
Bobby Quantitative Model
Marvell Technology is a fabless semiconductor designer whose core franchise is wired networking silicon — custom ASICs, electro-optics and copper transceivers, switches, storage controllers, and data-center processors — sold into hyperscale data center, carrier, enterprise, and consumer end markets. Marvell holds the second-highest market share in wired networking and has repositioned itself as a merchant-plus-custom silicon partner to the hyperscalers, competing directly with Broadcom while differentiating through bespoke AI accelerator and optical interconnect programs. The current investor debate is dominated by two forces: a genuine AI-driven demand inflection (data center now accounts for roughly $2.17 billion of a $2.74 billion quarterly revenue base, with total revenue up 36.6% year over year) versus the shock of the announced all-stock acquisition of Lumentum at a steep premium, which has triggered dilution concerns and a violent de-rating of the shares. Bulls frame the optics deal as a strategic land-grab in AI infrastructure and point to aggressive long-term revenue targets and custom AI chip wins; bears point to the ~42% one-month collapse, the loss of a major custom-silicon socket narrative, and the risk that Marvell is paying up for optical capability it could have partnered for.

People also watch

Nvidia

Nvidia

NVDA

Analysis
TSMC

TSMC

TSM

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis

BobbyInvestment Opinion: Should I buy MRVL Today?

Rating: Hold with a speculative accumulation bias. The core thesis is that Marvell's operating engine — 36.6% year-over-year revenue growth to $2.739 billion, six consecutive quarters of sequential acceleration, and gross margin up roughly 470bp to 53.1% — remains intact, but the all-stock Lumentum acquisition has introduced a dilution and integration overhang that the market is still actively repricing. The analyst consensus is a "strong_buy" (mean rating 1.395 across 40 analysts, 38 Buy / 5 Hold / 0 Sell) with an average target of $310.89, implying roughly +124.5% upside from $138.47, but that gap is so wide it more likely reflects stale targets than a clean mispricing.\n\nSupporting evidence for a constructive stance: forward PE of 18.8x sits near the bottom of the stock's three-year band versus 42x-138x during the AI euphoria, and PS of 8.3x is down from 28x-61x, meaning substantial skepticism is already discounted. Profitability has inflected hard — Q2 net income of $308 million on a 16.7% operating margin versus a $676 million loss in the year-ago quarter — and the balance sheet is internally funded with $3.93 billion of cash, debt-to-equity of 0.335, a current ratio of 2.01, and TTM free cash flow of $1.73 billion. Data center at $2.172 billion (79% of revenue) gives Marvell a structural seat in hyperscaler AI networking capex, and even the Street's $175 low target sits 26% above the current price.\n\nRisks that could invalidate the thesis: stock-based compensation of $326 million per quarter (~12% of revenue, larger than net income) compounds with Lumentum share issuance to pressure per-share economics; the clean quarterly net margin is only ~11.2% once the one-time $1.86 billion Q3 FY2026 other-income item is stripped out, so headline TTM net margin of 32.6% overstates earning power; and beta of 2.327 with a -57.79% max drawdown means a break of the $133.55 November 5 low could quickly test $100 (-28%) or the $70.69 52-week low (-49%). This Hold would upgrade to Buy on a decisive reclaim of the $168-$172 failed-rebound zone combined with evidence the Lumentum deal is accretive and custom AI silicon share is intact, and would downgrade to Sell on a break below $133.55 or a broad analyst target reset toward $175. Verdict: fairly valued to modestly undervalued on earnings, still at a premium on sales, and not yet a confirmed value base.

Sign up to view all

MRVL 12-Month Price Forecast

The fundamentals and the tape are telling opposite stories: Marvell's operating momentum is genuinely strong — 36.6% revenue growth, gross margin up ~470bp to 53.1%, and $1.73 billion of TTM free cash flow — yet the stock has fallen 42.4% in a month and sits at 26.1% of its annual range because the all-stock Lumentum deal transferred value to LITE holders and diluted existing shareholders at a depressed price. Valuation now embeds real skepticism at 18.8x forward earnings, but the 8.3x sales multiple and 13.6x EV/Sales remain above the ~5-7x typical of large-cap mixed-signal semis, so the de-rating is incomplete on the revenue line. The +124.5% gap to the $310.89 consensus target is more a warning about stale estimates than a clean upside signal, especially with two broker downgrades already on the tape. I would upgrade to bullish on a decisive reclaim of $172 plus confirmation that Lumentum is accretive and custom AI silicon share is intact, and downgrade to bearish on a break below $133.55 or a broad target reset toward $175.

Historical Price
Current Price $122.28
Average Target $217.50
High Target $450.00
Low Target $70.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Marvell Technology's 12-month outlook, with a consensus price target around $309.14 and implied upside of +152.8% versus the current price.

Average Target

$309.14

43 analysts

Implied Upside

+152.8%

vs. current price

Analyst Count

43

covering this stock

Price Range

$175 - $450

Analyst target range

Buy
38 (88%)
Hold
5 (12%)
Sell
0 (0%)

Coverage is deep and overwhelmingly bullish: 40 analysts with 38 Buy, 5 Hold, and 0 Sell ratings, a consensus recommendation of "strong_buy" (mean rating 1.395), and an average target price of $310.89. Against the current $138.47, that implies roughly +124.5% upside to consensus — an extraordinarily wide gap that reflects either a generational buying opportunity or stale targets that have not yet been marked down after the November collapse. The consensus is clearly leaning bullish, but the magnitude of the disconnect (the average target is more than double the current price) is itself a warning sign that estimates and price targets are lagging the news flow.\n\nThe target range of $175 to $450 is exceptionally wide — a 2.6x spread between low and high — signaling high uncertainty and low conviction in any single price point. The $450 high assumes multiple expansion back toward AI-euphoria levels, successful integration of Lumentum's optical franchise, and continued hyperscaler custom-silicon wins; the $175 low still sits 26% above the current price and implies only modest recovery, effectively pricing in margin compression and dilution without a growth re-rating. Notably, the low target is above the current price, meaning even the bear case on the Street is more constructive than the tape. Institutional actions show the first cracks: TD Cowen downgraded from Buy to Hold and BofA moved from Buy to Neutral on November 3, while B. Riley, Needham, Susquehanna, Rosenblatt, Wells Fargo, and RBC reiterated positive ratings — a pattern of reaffirmation alongside early downgrades that typically precedes a broader target reset. Consensus FY EPS of $28.95 (range $24.86-$32.48) and revenue of $75.7 billion look aggressive relative to the current $2.74 billion quarterly run-rate and warrant scrutiny before anchoring on the headline upside.

Drowning in data?

Find the real signal!

Bulls vs Bears: MRVL Investment Factors

The bear case currently has stronger near-term evidence: a 42.4% one-month collapse, a failed rebound at $168.80, a stock at 26% of its annual range, and two broker downgrades all confirm an active momentum unwind rather than a value base. The bull case rests on genuinely impressive fundamentals — 36.6% revenue growth, six consecutive quarters of sequential acceleration, gross margin up ~470bp to 53.1%, and a forward PE of 18.8x near multi-year lows — but those fundamentals have not yet stopped the bleeding. The single most important tension is whether the Lumentum acquisition proves accretive to AI optics leadership or is simply expensive dilution; if management demonstrates accretion and custom AI silicon share is intact, the +124.5% gap to the $310.89 consensus target becomes a generational entry, but if targets get reset toward the $175 low, the current price is merely fairly valued. Until the stock reclaims the $168-$172 failed-rebound zone, the tape argues for patience over conviction.

Bullish

  • Sequential revenue acceleration every quarter: Revenue climbed $1.895B → $2.006B → $2.075B → $2.219B → $2.418B → $2.739B over six straight quarters, with Q2 FY2027 up 36.6% year over year. This unbroken cadence of sequential growth is the profile the market historically pays premium multiples for, and it is intact despite the share-price collapse.
  • Data center now 79% of revenue: Data center contributed $2.172B of the $2.739B quarter, riding the AI networking buildout in custom ASICs, electro-optics and switches. Marvell holds the second-highest wired networking market share, giving it a structural position in hyperscaler capex that few merchant vendors can replicate.
  • Margins inflecting hard from the trough: Gross margin expanded from 48.4% in Q4 FY2026 to 52.1% in Q1 to 53.1% in Q2, a ~470bp sequential improvement driven by richer custom-silicon mix. Operating margin reached 16.7% and net income swung to $308M from a $676M loss in the year-ago quarter.
  • Valuation compressed to multi-year lows: Forward PE of 18.8x and trailing PE of 25.5x sit near the bottom of the stock's three-year band, versus 42x-138x during the AI euphoria. PS of 8.3x is down from 28x-61x, meaning the de-rating has already priced substantial skepticism.

Bearish

  • Lumentum deal triggers dilution shock: The announced all-stock acquisition of Lumentum at a steep premium drove a ~42.4% one-month collapse and a 58% drawdown from the $329.88 high. Paying up in equity for optical capability Marvell could have partnered for transfers value to LITE holders and dilutes existing shareholders at a depressed price.
  • Momentum unwind with no base formed: The stock sits at just 26.1% of its 52-week range, down 41.6% over three months and 29.5% over six months, with relative strength of -35.5 versus the S&P over one month. The November 11 bounce to $168.80 already failed, and the $133.55 low is the only nearby support.
  • Extreme volatility amplifies downside: Beta of 2.327 means a 10% index move implies roughly a 23% move here, and the max drawdown already hit -57.79%. With 29.6M shares trading on the latest down day, position sizing risk is acute and stop-loss levels are easily gapped through.
  • Hyperscaler concentration risk: Data center is ~79% of revenue, tying the franchise to a handful of hyperscaler capex budgets and custom-silicon socket decisions. The loss of a major custom-silicon narrative is precisely the fear that has compounded the optics-deal de-rating.

MRVL Technical Analysis

MRVL is in a violent, high-volatility downtrend that has overwhelmed what remains a positive longer-term trend: the stock is up 70.3% over the past year and 54.9% year-to-date, but the current price of $138.47 sits at just 26.1% of its 52-week range of $70.69 to $329.88 — a stunning round-trip from the highs. That positioning is the classic signature of a momentum unwind rather than a value base: the stock has surrendered roughly 58% from its peak (max drawdown -57.79%) and is now testing the lower third of its annual range, where support is thin and prior buyers are underwater. The 1-year gain is essentially a residual artifact of the first-half melt-up, not evidence of current strength.\n\nShort-term momentum is unambiguously negative and accelerating to the downside: the stock is down 42.4% in one month and 41.6% in three months, versus a 6.9% decline for the S&P 500 over the same month, producing a relative strength reading of -35.5 over one month and -35.1 over three months. This is a sharp divergence from the +62.2 one-year relative strength figure, which tells you the outperformance was front-loaded and has now fully reversed — a pattern consistent with trend reversal rather than benign mean reversion. The 6-month change of -29.5% confirms the deterioration is not a one-week shock; the November 5 close of $133.55 marked the capitulation low, and the bounce to $168.80 on November 11 has already failed, with the stock back at $138.47 on heavy volume of 29.6 million shares.\n\nKey levels are now well defined: the immediate support shelf is the $133.55 November 5 low, with the 52-week low of $70.69 as the catastrophic backstop, while resistance sits at the $168-$172 area (the failed November rebound) and then the $196-$218 zone where the October breakdown began. A decisive reclaim of $172 would signal the dilution shock is being digested; a break below $133.55 would open the door to a retest of the $100 handle and confirm a full trend failure. With a beta of 2.327, MRVL is roughly 2.3x as volatile as the S&P 500 — position sizing must account for the fact that a 10% index move implies a ~23% move here, which is precisely the kind of convexity that produced both the 70% annual gain and the 42% monthly loss.

Beta

2.33

2.33x market volatility

Max Drawdown

-61.4%

Largest decline past year

52-Week Range

$71-$330

Price range past year

Annual Return

+59.5%

Cumulative gain past year

PeriodMRVL ReturnS&P 500
1m-50.0%-9.7%
3m-48.4%-9.9%
6m-37.7%-7.5%
1y+59.5%+4.7%
ytd+36.8%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MRVL Fundamental Analysis

The revenue trajectory is genuinely strong and accelerating: Q2 FY2027 revenue of $2.739 billion grew 36.6% year over year, up sequentially from $2.418 billion in Q1 and $2.219 billion in the prior-year Q4, marking a clear inflection from the ~$1.8-$2.0 billion quarterly run-rate of fiscal 2025-2026. Data center is the engine at $2.172 billion, or roughly 79% of the quarter, with communications and other contributing $568 million — a concentration that is both the bull case (AI networking demand) and the risk (hyperscaler capex dependency). The multi-quarter cadence of $1.895B → $2.006B → $2.075B → $2.219B → $2.418B → $2.739B shows sequential acceleration every single quarter, which is exactly the profile the market pays up for — and exactly why the optics acquisition is being judged so harshly against that otherwise clean growth story.\n\nProfitability has inflected hard from the trough: Q2 net income of $308 million on a 53.1% gross margin and 16.7% operating margin, versus a loss of $676 million in the year-ago quarter when gross margin collapsed to 23.0%. Gross margin has expanded from 48.4% in Q4 FY2026 to 52.1% in Q1 to 53.1% in Q2, a ~470bp sequential improvement that reflects richer custom-silicon mix and operating leverage; net margin has moved from 1.4% in Q1 to 11.2% in Q2, though the Q1 figure was distorted by a $267 million other-expense line. Note that the trailing twelve-month net margin of 32.6% is inflated by a one-time $1.86 billion other-income item in Q3 FY2026 (the quarter with $1.90 billion of net income on $2.07 billion of revenue) — investors should anchor on the ~11-12% clean quarterly net margin and the 16-17% operating margin rather than the headline TTM figure.\n\nThe balance sheet is solid and internally funded: debt-to-equity of 0.335, current ratio of 2.01, and $3.93 billion of cash at the end of Q2 against $605.5 million of quarterly operating cash flow and $478.8 million of free cash flow (TTM FCF $1.73 billion). ROE of 18.7% and ROA of 4.1% are respectable for a fabless model, and capex is modest at $126.7 million (4.6% of revenue), leaving ample room for the $200 million quarterly buyback and $53.9 million dividend. The caveat is stock-based compensation of $326 million in the quarter — roughly 12% of revenue and larger than net income — which is a real dilution drag, and the $1.27 billion acquisition outflow in Q1 plus the pending all-stock Lumentum deal means the cash-rich, low-leverage profile is about to be levered up in share count terms.

Quarterly Revenue

$2.7B

2026-08

Revenue YoY Growth

+36.5%

YoY Comparison

Gross Margin

53.1%

Latest Quarter

Free Cash Flow

$1.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Data center
Communications and other

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MRVL Overvalued?

Because net income is positive ($308 million in the latest quarter, $0.34 EPS), the PE ratio is the appropriate primary metric, and it tells a bifurcated story: the trailing PE of 25.5x looks modest for a 36.6%-growth semiconductor franchise, but that trailing figure is flattered by the one-time Q3 FY2026 gain, while the forward PE of 18.8x on consensus FY estimates implies the market expects earnings to roughly double. The gap between trailing and forward multiples — and the fact that the stock has fallen 58% from its high while forward estimates have held — means the market is now pricing meaningful skepticism about the durability of that earnings ramp, particularly post-Lumentum dilution.\n\nOn peer-relative grounds the stock is no longer expensive on earnings but remains rich on sales: PS of 8.3x and EV/Sales of 13.6x (the latter inflated by the enterprise-value calculation) sit well above the ~5-7x sales typical of large-cap analog/mixed-signal semis, while EV/EBITDA of 15.4x is roughly in line with a quality semiconductor peer group trading in the mid-teens. The PEG ratio of -0.063 is not meaningful given the distorted trailing earnings base and should be disregarded. The read-through is that the de-rating has compressed the earnings multiple to a discount versus the stock's own history while leaving the sales multiple at a premium — the market is paying for the revenue trajectory but no longer crediting the margin/dilution story.\n\nHistorical context is stark: the stock's own PE history over the past three years ranges from negative (loss quarters) to 138x (Q2 FY2027 reported), 1,055x (Q1 FY2027), and 42x (Q4 FY2026), with PS ratios that ran from 28x to 61x during the AI euphoria. At 8.3x sales and 25.5x trailing earnings, MRVL is now near the bottom of its own multi-year valuation band — a level last seen in the 2023-2024 downturn — which either signals a genuine value opportunity if the AI networking cycle holds, or reflects the market's judgment that peak margins and peak growth are behind it. The burden of proof now sits with management to demonstrate that Lumentum is accretive and that custom AI silicon share is intact.

PE

25.5x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 11x~1055x

vs. Industry Avg

54.4x

Industry PE ~54.4x*

EV/EBITDA

15.4x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on dilution and earnings quality. The all-stock Lumentum deal at a steep premium expands the share count just as stock-based compensation already runs $326M per quarter — roughly 12% of revenue and larger than the $308M net income — so per-share economics face a double drag. The headline TTM net margin of 32.6% is inflated by a one-time $1.86B other-income item in Q3 FY2026; the clean quarterly net margin is closer to 11.2%, and Q1 FY2027 net income was only $34.5M after a $266.8M other-expense line, showing how volatile reported earnings are. Revenue concentration is severe, with data center at $2.172B of $2.739B (79%), tying results directly to a handful of hyperscaler capex programs.

Market and competitive risks are dominated by valuation compression and a broken chart. Beta of 2.327 means MRVL moves roughly 2.3x the S&P, so a 10% index drawdown implies a ~23% hit, and the stock has already delivered a -57.79% max drawdown. Competition from Broadcom — whose AI semiconductor revenue surged 221% to $16.7B — pressures Marvell's custom-silicon share, while the optics deal was itself a response to competitive urgency. The $310.89 average target versus a $138.47 price signals targets are stale and vulnerable to a broad reset, and TD Cowen and BofA downgrades on November 3 suggest the reset has begun. Sector rotation out of high-multiple semis ahead of Nvidia earnings adds a further macro overlay.

Worst-case scenario: Lumentum integration disappoints, a hyperscaler reallocates a custom AI socket to Broadcom, and consensus FY EPS of $28.95 gets cut sharply, forcing analysts to mark targets toward the $175 low — or below it if the tape breaks. A decisive break of the $133.55 November 5 low would open a retest of the $100 handle, and the 52-week low of $70.69 represents the catastrophic backstop. From the current $138.47, a move to the $70.69 low would be a loss of roughly -49%, while a slide to $100 would be about -28%; with beta at 2.327, such a move could occur within weeks if the index sells off.

FAQ

From a pure risk/reward standpoint the setup is asymmetric but not yet confirmed: the stock trades at $138.47 against a $310.89 average analyst target (+124.5%) and even the $175 low target sits 26% above the tape, while forward PE of 18.8x is near the bottom of a three-year band that ran from 42x to 138x. The operating evidence supports the bulls — revenue up 36.6% year over year to $2.739 billion, six consecutive quarters of sequential acceleration, gross margin up roughly 470bp to 53.1%, and $1.73 billion of TTM free cash flow — but the tape does not: a 42.4% one-month decline, a failed bounce at $168.80, and two broker downgrades (TD Cowen and BofA on November 3) show an active momentum unwind. The biggest downside risk is a break of the $133.55 November 5 low, which with beta of 2.327 could quickly produce a -28% move to $100 or worse. It is a good buy for patient investors with a 2-3 year horizon who size positions for a 50% drawdown and are willing to wait for confirmation that Lumentum is accretive and custom AI silicon share is intact; it is not a good buy for anyone who needs the bottom to be in, because no base has formed yet.